MARKET

RXST

RXST

Rxsight, Inc.
NASDAQ
5.51
+0.26
+4.95%
Opening 12:51 07/16 EDT
OPEN
5.14
PREV CLOSE
5.25
HIGH
5.52
LOW
5.06
VOLUME
620.88K
TURNOVER
--
52 WEEK HIGH
13.22
52 WEEK LOW
4.480
MARKET CAP
228.09M
P/E (TTM)
-4.8520
1D
5D
1M
3M
1Y
5Y
1D
Analysts Offer Insights on Healthcare Companies: RxSight (RXST), Kazia Therapeutics (KZIA) and Crescent Biopharma (CBIO)
TipRanks · 6h ago
RxSight Names Aziz Mottiwala As CEO And Ron Kurtz As CMO Amid Standalone 2026 Sales Outlook Cut
NASDAQ · 10h ago
RxSight Tarsus CEO Ron Kurtz to depart role, Aziz Mottiwala to succeed
TipRanks · 20h ago
RxSight appoints new CEO
Seeking Alpha · 20h ago
RxSight names Aziz Mottiwala CEO, Ron Kurtz to become chief medical officer
PUBT · 20h ago
RxSight Appoints Aziz Mottiwala President, CEO, Effective July 20, Succeeding Ron Kurtz
Benzinga · 20h ago
*RxSight Names Aziz Mottiwala CEO, Ron Kurtz to Continue to Serve as Chief Medical Officer
Dow Jones · 20h ago
RXSIGHT - RON KURTZ, M.D. TO RESIGN FROM BOARD; AZIZ MOTTIWALA TO JOIN BOARD
Reuters · 20h ago
More
About RXST
RxSight, Inc. is a commercial-stage medical technology company engaged in providing customized vision to patients following cataract surgery. Its RxSight Light Adjustable Lens system (RxSight system) is a cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system is composed of RxSight Light Adjustable Lens (LAL), RxSight Light Delivery Device (LDD) and related accessories. The LAL is an intraocular lens (IOL) made from the silicone-based photosensitive material that undergoes controlled changes in refractive power when exposed to specific ultraviolet (UV) light patterns generated by the LDD. Its LAL uses a silicone formulation that enables changing the mechanical and optical properties of the lens following implantation. The LDD uses software and algorithms to deliver a short UV light exposure treatment that polymerizes specific portions of the lens and allows doctors to adjust spherical and cylindrical refraction.

Webull offers Rxsight Inc stock information, including NASDAQ: RXST real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RXST stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RXST stock methods without spending real money on the virtual paper trading platform.